MCTA

Charming Medical Ltd MCTA

NasdaqunknownHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $6.2M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$4.81M

Quarter to Mar 31

Net income

$-22.6K

Quarter to Mar 31

Free cash flow

$-1.56M

Quarter to Mar 31

Operating margin

-0.6%

Quarter to Mar 31

Top Institutional Holders

as of Q2 2026
$1.03M total
UBS Group AG
$711.8K-2.8%
GEODE CAPITAL MANAGEMENT, LLC
$315.6K0.0%
JFS WEALTH ADVISORS, LLC
$00.0%
See all 3 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2026
EDGAR

Net Income

FY 2026
EDGAR

EPS (Diluted)

FY 2026
EDGAR

Operating Margin

FY 2026
EDGAR

ROIC

FY 2026
EDGAR

Free Cash Flow

FY 2026
EDGAR

Debt/Equity

FY 2026
EDGAR

Loading ratio trend…

MCTA key financials by period

Reported revenue, net income and operating margin by fiscal year, from Charming Medical Ltd's annual filings on SEC EDGAR.

Charming Medical Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2026$4.8M$-22.6K-0.6%
FY 2025$6.2M$1.2M22.3%
FY 2024$6.0M$777.8K16.8%
Source: MCTA filings on SEC EDGAR →

About Charming Medical Ltd (MCTA): stock profile, AI score and financials

Charming Medical Ltd (MCTA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MCTA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $6.2m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2026), Charming Medical Ltd reports quarterly revenue of $4.8M, net income of $-22.6K, an operating margin of -0.6%. Top institutional holders of MCTA by reported 13-F value include UBS Group AG, GEODE CAPITAL MANAGEMENT, JFS WEALTH ADVISORS, based on the most recent SEC filings. MCTA trades on the Nasdaq exchange and files with the SEC under CIK 2035992. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MCTA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Charming Medical Ltd directly from SEC EDGAR.

SEC EDGAR: CIK 2035992 →